Original Source(s)
Related Content
Virtual Staining and the Next Era of Pathology
How AI enables scalable biomarker analysis that preserves tissue samples, addressing some of the most persistent bottlenecks in clinical care and research
by Kenneth To
June 19, 2026
-
6 min
ASCO26: Sara Tolaney, MD, MPH, ASCENT-03
Dana-Farber Cancer Institute's Dr. Sara Tolaney from the ASCENT-03 stud in breast cancer. The data further strengthens the case for approval of sacituzumab govitecan as first-line treatment for patients with advanced triple-negative breast cancer.
July 1, 2026
-
1 min
The Secrets of the Gut
Going beyond the gut: why microbiome testing is the next big thing in drug development
July 20, 2026
-
6 min
